Susquehanna International Group, LLP Oramed Pharmaceuticals Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $33,687 - $50,629	19,700 New	19,700 $45,000
Q4 2022 Feb 14, 2023	BUY	$6.21 - $12.03 $571,941 - $1.11 Million	92,100 Added 451.47%	112,500 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $80,960 - $174,416	-17,600 Reduced 46.32%	20,400 $132,000
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $117,924 - $285,300	-31,700 Reduced 45.48%	38,000 $174,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $20,475 - $34,725	2,500 Added 3.72%	69,700 $603,000

Q4 2021 Feb 14, 2022	SELL	$12.98 - $29.75 $1.4 Million - $3.22 Million	-108,100 Reduced 61.67%	67,200 $960,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $1.19 Million - $2.33 Million	98,000 Added 126.78%	175,300 $3.85 Million
Q2 2021 Aug 11, 2021	BUY	$8.34 - $14.59 $78,396 - $137,146	9,400 Added 13.84%	77,300 $1.03 Million
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $162,470 - $436,205	38,500 Added 130.95%	67,900 $690,000
Q4 2020 Feb 16, 2021	BUY	$2.48 - $4.64 $14,880 - $27,839	6,000 Added 25.64%	29,400 $125,000
Q3 2020 Nov 16, 2020	SELL	$2.58 - $4.16 $62,952 - $101,504	-24,400 Reduced 51.05%	23,400 $61,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $4.12 $18,655 - $26,780	-6,500 Reduced 11.97%	47,800 $169,000
Q1 2020 May 15, 2020	BUY	$2.6 - $5.5 $19,760 - $41,800	7,600 Added 16.27%	54,300 $165,000
Q4 2019 Feb 14, 2020	BUY	$2.43 - $5.74 $113,481 - $268,058	46,700 New	46,700 $241,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.